Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 653

1.

Investigation of the HSPG2 Gene in Tardive Dyskinesia - New Data and Meta-Analysis.

Zai CC, Lee FH, Tiwari AK, Lu JY, de Luca V, Maes MS, Herbert D, Shahmirian A, Cheema SY, Zai GC, Atukuri A, Sherman M, Shaikh SA, Tampakeras M, Freeman N, King N, Müller DJ, Greenbaum L, Lerer B, Voineskos AN, Potkin SG, Lieberman JA, Meltzer HY, Remington G, Kennedy JL.

Front Pharmacol. 2018 Sep 18;9:974. doi: 10.3389/fphar.2018.00974. eCollection 2018.

2.

Association study of Disrupted-In-Schizophrenia-1 gene variants and tardive dyskinesia.

Lu JY, Tiwari AK, Zai GC, Rastogi A, Shaikh SA, Müller DJ, Voineskos AN, Potkin SG, Lieberman JA, Meltzer HY, Remington G, Wong AHC, Kennedy JL, Zai CC.

Neurosci Lett. 2018 Aug 15;686:17-22. doi: 10.1016/j.neulet.2018.08.007. [Epub ahead of print]

PMID:
30118782
3.

The past and future of novel, non-dopamine-2 receptor therapeutics for schizophrenia: A critical and comprehensive review.

Girgis RR, Zoghbi AW, Javitt DC, Lieberman JA.

J Psychiatr Res. 2018 Jul 21. pii: S0022-3956(18)30041-4. doi: 10.1016/j.jpsychires.2018.07.006. [Epub ahead of print] Review.

PMID:
30055853
4.

The reliability of motor evoked potentials to predict dorsiflexion injuries during lumbosacral deformity surgery: importance of multiple myotomal monitoring.

Lieberman JA, Lyon R, Jasiukaitis P, Berven SH, Burch S, Feiner J.

Spine J. 2018 Jul 17. pii: S1529-9430(18)31004-0. doi: 10.1016/j.spinee.2018.07.006. [Epub ahead of print]

PMID:
30025994
5.

Psychotic Disorders.

Lieberman JA, First MB.

N Engl J Med. 2018 Jul 19;379(3):270-280. doi: 10.1056/NEJMra1801490. Review. No abstract available.

PMID:
30021088
6.

A predictive model for conversion to psychosis in clinical high-risk patients.

Ciarleglio AJ, Brucato G, Masucci MD, Altschuler R, Colibazzi T, Corcoran CM, Crump FM, Horga G, Lehembre-Shiah E, Leong W, Schobel SA, Wall MM, Yang LH, Lieberman JA, Girgis RR.

Psychol Med. 2018 Jun 28:1-10. doi: 10.1017/S003329171800171X. [Epub ahead of print]

PMID:
29950184
7.

Are there different subtypes of eosinophilic esophagitis?

Lieberman JA.

Ann Allergy Asthma Immunol. 2018 Aug;121(2):143-144. doi: 10.1016/j.anai.2018.05.023. Epub 2018 Jun 1. No abstract available.

PMID:
29860052
8.

Disease modifying effects of antipsychotic drugs in schizophrenia: a clinical and neurobiological perspective.

Lieberman JA.

World Psychiatry. 2018 Jun;17(2):163-165. doi: 10.1002/wps.20543. No abstract available.

9.

A randomized, double-blinded, placebo-controlled study of the use of viscous oral cromolyn sodium for the treatment of eosinophilic esophagitis.

Lieberman JA, Zhang J, Whitworth J, Cavender C.

Ann Allergy Asthma Immunol. 2018 May;120(5):527-531. doi: 10.1016/j.anai.2018.03.006. Epub 2018 Mar 12.

PMID:
29544738
10.

Pathophysiology of drug induced weight and metabolic effects: findings from an RCT in healthy volunteers treated with olanzapine, iloperidone, or placebo.

Ballon JS, Pajvani UB, Mayer LE, Freyberg Z, Freyberg R, Contreras I, Rosenbaum M, Leibel RL, Lieberman JA.

J Psychopharmacol. 2018 May;32(5):533-540. doi: 10.1177/0269881118754708. Epub 2018 Feb 15.

PMID:
29444618
11.

The environment and food allergy.

Lieberman JA, Greenhawt M, Nowak-Wegrzyn A.

Ann Allergy Asthma Immunol. 2018 May;120(5):455-457. doi: 10.1016/j.anai.2018.01.010. Epub 2018 Feb 2. No abstract available.

PMID:
29410214
12.

Understanding fibrosis in eosinophilic esophagitis: Are we there yet?

Armbruster-Lee J, Cavender CP, Lieberman JA, Samarasinghe AE.

J Leukoc Biol. 2018 Jul;104(1):31-40. doi: 10.1002/JLB.5MR1017-395R. Epub 2018 Jan 29. Review.

PMID:
29377264
13.

Identical twins with XLA requiring differing amounts of 20% subcutaneous immunoglobulin secondary to protein-losing enteropathy.

Lan J, Eshun J, Lieberman JA.

J Allergy Clin Immunol Pract. 2018 May - Jun;6(3):1073-1074. doi: 10.1016/j.jaip.2017.11.030. Epub 2018 Jan 12. No abstract available.

PMID:
29339123
14.

Hippocampal dysfunction in the pathophysiology of schizophrenia: a selective review and hypothesis for early detection and intervention.

Lieberman JA, Girgis RR, Brucato G, Moore H, Provenzano F, Kegeles L, Javitt D, Kantrowitz J, Wall MM, Corcoran CM, Schobel SA, Small SA.

Mol Psychiatry. 2018 Aug;23(8):1764-1772. doi: 10.1038/mp.2017.249. Epub 2018 Jan 9.

PMID:
29311665
15.

Allergists' opinions on anaphylaxis and epinephrine administration-a case-based survey.

Lieberman JA, Lieberman P, Wang J.

J Allergy Clin Immunol Pract. 2018 May - Jun;6(3):1075-1077.e1. doi: 10.1016/j.jaip.2017.11.031. Epub 2018 Jan 4. No abstract available.

PMID:
29306683
16.

Cost-effectiveness of HLA-DQB1/HLA-B pharmacogenetic-guided treatment and blood monitoring in US patients taking clozapine.

Girardin FR, Poncet A, Perrier A, Vernaz N, Pletscher M, F Samer C, Lieberman JA, Villard J.

Pharmacogenomics J. 2018 Jan 3. doi: 10.1038/s41397-017-0004-2. [Epub ahead of print]

PMID:
29298994
17.

Psychiatrists Diagnosing the President - Moral Imperative or Ethical Violation?

Lieberman JA.

N Engl J Med. 2018 Feb 1;378(5):483-484. doi: 10.1056/NEJMc1716751. Epub 2017 Dec 27. No abstract available.

18.

Nutrition education for cardiovascular disease prevention in individuals with spinal cord injuries: study protocol for a randomized controlled trial.

Lieberman JA, McClelland JW, Goff DC Jr, Racine E, Dulin MF, Bauman WA, Niemeier J, Hirsch MA, Norton HJ, Moore CG.

Trials. 2017 Dec 4;18(1):584. doi: 10.1186/s13063-017-2263-2.

19.

Utility of Imaging-Based Biomarkers for Glutamate-Targeted Drug Development in Psychotic Disorders: A Randomized Clinical Trial.

Javitt DC, Carter CS, Krystal JH, Kantrowitz JT, Girgis RR, Kegeles LS, Ragland JD, Maddock RJ, Lesh TA, Tanase C, Corlett PR, Rothman DL, Mason G, Qiu M, Robinson J, Potter WZ, Carlson M, Wall MM, Choo TH, Grinband J, Lieberman JA.

JAMA Psychiatry. 2018 Jan 1;75(1):11-19. doi: 10.1001/jamapsychiatry.2017.3572.

PMID:
29167877
20.

Unproven Diagnostic Tests for Food Allergy.

Hammond C, Lieberman JA.

Immunol Allergy Clin North Am. 2018 Feb;38(1):153-163. doi: 10.1016/j.iac.2017.09.011. Review.

PMID:
29132671
21.

Correction to: Changes in transcranial motor evoked potentials during hemorrhage are associated with increased serum propofol concentrations.

Lieberman JA, Feiner J, Rollins M, Lyon R, Jasiukaitis P.

J Clin Monit Comput. 2018 Jun;32(3):581. doi: 10.1007/s10877-017-0075-2.

PMID:
29119425
22.

Eliminating the Glass Ceiling in Academic Psychiatry.

Lieberman JA, Ehrhardt AA, Simpson HB, Arbuckle MR, Fyer AJ, Essock SM.

Acad Psychiatry. 2018 Aug;42(4):523-528. doi: 10.1007/s40596-017-0810-5. Epub 2017 Nov 6. No abstract available.

23.

A Randomized, Double-Blind, Placebo-Controlled Clinical Trial of Tocilizumab, An Interleukin-6 Receptor Antibody, For Residual Symptoms in Schizophrenia.

Girgis RR, Ciarleglio A, Choo T, Haynes G, Bathon JM, Cremers S, Kantrowitz JT, Lieberman JA, Brown AS.

Neuropsychopharmacology. 2018 May;43(6):1317-1323. doi: 10.1038/npp.2017.258. Epub 2017 Nov 1.

PMID:
29090685
24.

Alive but not well: the limited validity but continued utility of the concept of schizophrenia.

Zoghbi AW, Lieberman JA.

Psychol Med. 2018 Jan;48(2):245-246. doi: 10.1017/S0033291717001969. Epub 2017 Oct 26.

PMID:
29072155
25.

ZATT (ZNF451)-mediated resolution of topoisomerase 2 DNA-protein cross-links.

Schellenberg MJ, Lieberman JA, Herrero-Ruiz A, Butler LR, Williams JG, Muñoz-Cabello AM, Mueller GA, London RE, Cortés-Ledesma F, Williams RS.

Science. 2017 Sep 29;357(6358):1412-1416. doi: 10.1126/science.aam6468. Epub 2017 Sep 14.

26.

Changes in transcranial motor evoked potentials during hemorrhage are associated with increased serum propofol concentrations.

Lieberman JA, Feiner J, Rollins M, Lyon R.

J Clin Monit Comput. 2018 Jun;32(3):541-548. doi: 10.1007/s10877-017-0057-4. Epub 2017 Aug 30. Erratum in: J Clin Monit Comput. 2018 Jun;32(3):581.

PMID:
28856576
27.

Adult-onset food allergies.

Ramesh M, Lieberman JA.

Ann Allergy Asthma Immunol. 2017 Aug;119(2):111-119. doi: 10.1016/j.anai.2017.05.014. Review. No abstract available.

PMID:
28801016
28.

Pediatric Angioedema.

Pattanaik D, Lieberman JA.

Curr Allergy Asthma Rep. 2017 Aug 8;17(9):60. doi: 10.1007/s11882-017-0729-7. Review.

PMID:
28791569
29.

A Longitudinal Study of Violent Behavior in a Psychosis-Risk Cohort.

Brucato G, Appelbaum PS, Lieberman JA, Wall MM, Feng T, Masucci MD, Altschuler R, Girgis RR.

Neuropsychopharmacology. 2018 Jan;43(2):264-271. doi: 10.1038/npp.2017.151. Epub 2017 Jul 26.

PMID:
28745307
30.

Association Study of Serotonin 3 Receptor Subunit Gene Variants in Antipsychotic-Induced Weight Gain.

Zai CC, Tiwari AK, Chowdhury NI, Brandl EJ, Shaikh SA, Freeman N, Lieberman JA, Meltzer HY, Kennedy JL, Müller DJ.

Neuropsychobiology. 2016;74(3):169-175. doi: 10.1159/000457903. Epub 2017 May 23.

31.

The Long-Term Effects of Antipsychotic Medication on Clinical Course in Schizophrenia.

Goff DC, Falkai P, Fleischhacker WW, Girgis RR, Kahn RM, Uchida H, Zhao J, Lieberman JA.

Am J Psychiatry. 2017 Sep 1;174(9):840-849. doi: 10.1176/appi.ajp.2017.16091016. Epub 2017 May 5. Review. Erratum in: Am J Psychiatry. 2017 Aug 1;174(8):805.

PMID:
28472900
32.

Genetic study of neuregulin 1 and receptor tyrosine-protein kinase erbB-4 in tardive dyskinesia.

Zai CC, Tiwari AK, Chowdhury NI, Yilmaz Z, de Luca V, Müller DJ, Potkin SG, Lieberman JA, Meltzer HY, Voineskos AN, Remington G, Kennedy JL.

World J Biol Psychiatry. 2017 Apr 10:1-5. doi: 10.1080/15622975.2017.1301681. [Epub ahead of print]

PMID:
28394697
33.

An analysis of anaphylaxis cases at a single pediatric emergency department during a 1-year period.

Wright CD, Longjohn M, Lieberman PL, Lieberman JA.

Ann Allergy Asthma Immunol. 2017 Apr;118(4):461-464. doi: 10.1016/j.anai.2017.02.002.

PMID:
28390586
34.

Raising the standard of care for schizophrenia is an achievable goal.

Stroup TS, Lieberman JA.

Aust N Z J Psychiatry. 2017 Jun;51(6):637-638. doi: 10.1177/0004867417700277. Epub 2017 Apr 4. No abstract available.

PMID:
28374601
35.

Wells Syndrome with Bullous Lesions.

Lieberman JA.

J Allergy Clin Immunol Pract. 2017 Sep - Oct;5(5):1410. doi: 10.1016/j.jaip.2017.02.017. Epub 2017 Mar 27. No abstract available.

PMID:
28351790
36.

Chd7 is indispensable for mammalian brain development through activation of a neuronal differentiation programme.

Feng W, Kawauchi D, Körkel-Qu H, Deng H, Serger E, Sieber L, Lieberman JA, Jimeno-González S, Lambo S, Hanna BS, Harim Y, Jansen M, Neuerburg A, Friesen O, Zuckermann M, Rajendran V, Gronych J, Ayrault O, Korshunov A, Jones DT, Kool M, Northcott PA, Lichter P, Cortés-Ledesma F, Pfister SM, Liu HK.

Nat Commun. 2017 Mar 20;8:14758. doi: 10.1038/ncomms14758.

37.

Variability in, variability out: best practice recommendations to standardize pre-analytical variables in the detection of circulating and tissue microRNAs.

Khan J, Lieberman JA, Lockwood CM.

Clin Chem Lab Med. 2017 May 1;55(5):608-621. doi: 10.1515/cclm-2016-0471. Review.

38.

Pharmacogenetic Analysis of Functional Glutamate System Gene Variants and Clinical Response to Clozapine.

Taylor DL, Tiwari AK, Lieberman JA, Potkin SG, Meltzer HY, Knight J, Remington G, Müller DJ, Kennedy JL.

Mol Neuropsychiatry. 2017 Feb;2(4):185-197. doi: 10.1159/000449224. Epub 2016 Oct 12.

39.

Baseline demographics, clinical features and predictors of conversion among 200 individuals in a longitudinal prospective psychosis-risk cohort.

Brucato G, Masucci MD, Arndt LY, Ben-David S, Colibazzi T, Corcoran CM, Crumbley AH, Crump FM, Gill KE, Kimhy D, Lister A, Schobel SA, Yang LH, Lieberman JA, Girgis RR.

Psychol Med. 2017 Aug;47(11):1923-1935. doi: 10.1017/S0033291717000319. Epub 2017 Mar 2.

40.

Association study between the neurexin-1 gene and tardive dyskinesia.

Lanning R, Lett TA, Tiwari AK, Brandl EJ, de Luca V, Voineskos AN, Potkin SG, Lieberman JA, Meltzer HY, Müller DJ, Remington G, Kennedy JL, Zai CC.

Hum Psychopharmacol. 2017 Jan;32(1). doi: 10.1002/hup.2568.

PMID:
28120489
41.

Adherence and systemic reaction rates to allergy immunotherapy among veterans.

Ellenburg JT, Lieberman JA, Pattanaik D.

Allergy Rhinol (Providence). 2016 Jan 1;7(3):127-130. doi: 10.2500/ar.2016.7.0170.

42.

The year in review: The best of 2016 in the Annals.

Marshall GD Jr, Bielory L, Walter Canonica G, Desai M, Ellis AK, Hsieh FH, Grayson MH, Greenhawt M, Lieberman JA, Montanaro A, Oppenheimer J.

Ann Allergy Asthma Immunol. 2017 Jan;118(1):4-9. doi: 10.1016/j.anai.2016.11.005. Review. No abstract available.

PMID:
28007087
43.

Back to the future: Research renewed on the clinical utility of psychedelic drugs.

Lieberman JA, Shalev D.

J Psychopharmacol. 2016 Dec;30(12):1198-1200. No abstract available.

PMID:
27909166
44.

Impact of histamine receptors H1 and H3 polymorphisms on antipsychotic-induced weight gain.

Tiwari AK, Zhang D, Pouget JG, Zai CC, Chowdhury NI, Brandl EJ, Qin L, Freeman N, Lieberman JA, Meltzer HY, Kennedy JL, Müller DJ.

World J Biol Psychiatry. 2016 Dec 15:1-9. doi: 10.1080/15622975.2016.1262061. [Epub ahead of print]

PMID:
27855565
45.

Distinct Relationships Between Visual and Auditory Perceptual Abnormalities and Conversion to Psychosis in a Clinical High-Risk Population.

Lehembre-Shiah E, Leong W, Brucato G, Abi-Dargham A, Lieberman JA, Horga G, Girgis RR.

JAMA Psychiatry. 2017 Jan 1;74(1):104-106. doi: 10.1001/jamapsychiatry.2016.3055. No abstract available.

46.

Dr Kantrowitz and Colleagues Reply.

Kantrowitz JT, Medalia A, Keefe RS, Harvey PD, Bruder G, Barch DM, Choo T, Lee S, Lieberman JA.

J Clin Psychiatry. 2016 Oct;77(10):e1353. doi: 10.4088/JCP.16lr10887a. No abstract available.

47.

Probable metronidazole induced serum sickness-like reaction in a paediatric patient.

VanCleave HZ, Sanchez AC, Lieberman JA, Ellenburg JT, Mabry WA.

J Clin Pharm Ther. 2016 Dec;41(6):736-738. doi: 10.1111/jcpt.12448. Epub 2016 Sep 24.

PMID:
27663456
48.

The role of the ITIH3 rs2535629 variant in antipsychotic response.

Brandl EJ, Lett TA, Chowdhury NI, Tiwari AK, Bakanidze G, Meltzer HY, Potkin SG, Lieberman JA, Kennedy JL, Müller DJ.

Schizophr Res. 2016 Oct;176(2-3):131-135. doi: 10.1016/j.schres.2016.06.032. Epub 2016 Jul 6.

PMID:
27396837
49.

AOT and Long-Term Use of Antipsychotics.

Sharfstein SS, Lieberman JA, Talbott JA.

Psychiatr Serv. 2016 Jul 1;67(7):811. doi: 10.1176/appi.ps.670703. No abstract available.

PMID:
27363353
50.

Summer camps and food allergy: What do we not know?

Lieberman JA.

Ann Allergy Asthma Immunol. 2016 Jun;116(6):482-3. doi: 10.1016/j.anai.2016.03.033. No abstract available.

PMID:
27264562

Supplemental Content

Loading ...
Support Center